Catalyst Wire Dossier Catalyst Wire Dossier

Bevacizumab-awwb

bevacizumab · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bevacizumab-awwb, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation [Phase 3]

See pricing